This article was originally published in The Rose Sheet
Cosmetic, Toiletry and Fragrance Association will hold a "Meet the Regulators" seminar Feb. 1 in Washington, D.C, trade group reports. Seminar "provides a unique opportunity to hear key Food and Drug Administration officials and other food and drug experts review current agency initiatives and recent actions impacting cosmetic and OTC drug products." Participants will include staffers from CFSAN and the Office of Cosmetics & Colors, as well as CDER's new Office of Nonprescription Products. In addition to domestic issues, meeting will address international harmonization and "FDA's view of global regulatory initiatives," CTFA says...
You may also be interested in...
Like other hand sanitizer manufacturers, WillSpeed Technology claims its GermBloc “kills 99.99% of germs.” Plaintiffs in a proposed class action filed in Massachusetts federal court allege the claim “grossly overstates” the product’s efficacy, deceiving consumers and endangering them with false confidence.
Keeping Track: US FDA Set For Speed With Approvals Of Inqovy, Rukobia, Dojolvy, Phesgo; Keytruda Loses Chance At AA In HCC
The latest drug development news and highlights from the Pink Sheet’s FDA Performance Tracker.
Syndax CEO also says US FDA’s virtual meetings would benefit from having advisory committee members on camera, which may be a technology challenge.